This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kezic, S. Articles by Verberk, M. M Search for Related Content PubMed PubMed Citation Articles by Kezic, S. Articles by Verberk, M. M Social Bookmarking                         What's this?

Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy

Coronel Institute, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands, s.kezic{at}amc.uva.nl

Florentine Calkoen

Coronel Institute, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands

Mira AM Wenker

Coronel Institute, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands, NOTOX BV, ‘s-Hertogenbosch, The Netherlands

John JL Jacobs

Coronel Institute, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands, Department of Pathobiology, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands

Maarten M Verberk

Coronel Institute, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands

In the present study, we investigate whether genetic polymorphism in enzymes involved in the metabolism of organic solvents influences susceptibility to chronic solvent encephalopathy (CSE), which is one of the major effects of long-term exposure to organic solvents. Polymorphisms in the genes encoding CYP1A1, CYP2E1, EPHX1, GSTM1, GSTT1 and GSTP1 enzymes were determined in a group of male CSE patients (N = 97) and controls (N = 214). The selection of the patients was based on a standard diagnostic protocol, including interviews, neuropsychological tests and questionnaires directed to somatic, cognitive and mood symptoms and exposure, in combination with well-defined decision rules. As controls, healthy workers of similar socio-economic background, without memory problems and with no known exposure to organic solvents, were included in the study. Comparing patients and controls, higher frequencies of the variant *5B allele of the CYP2E1 gene (OR: 5.8; 95% CI: 1.8-18.8) and of the variant GSTP1*C allele (OR: 0.40; 95% CI: 0.17-0.94) were found. Homozygous carriers of the exon 4 EPHX1 Arg¹³⁹ variant allele had a lower risk (OR:0.25; 95% CI: 0.06-1.13).

The present study indicates that genetic polymorphism of CYP2E1, EPHX1 and GSTP1 modify the risk of developing CSE.

Key Words: biotransformation enzymes • chronic solvent encephalopathy • genetic polymorphism • organic solvents

References

• Abdel-Rahman, S. Z., Ammenheuser, M. M. and Omiecinski, C. J. 2005: Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1). Toxicological Sciences 85, 624-631.[Abstract/Free Full Text]
• Ahmadi, A., Fredrikson, M. and Jerregard, H.et al. 2000: GSTM1 and mEPHX polymorphisms in Parkinson’s disease and age of onset. Biochemical Biophysical Research Communication 269, 676-680.
• Ahmadi, A., Jonsson, P. and Flodin, U.et al. 2002: Interaction between smoking and glutathione S-transferase polymorphisms in solvent-induced chronic toxic encephalopathy. Toxicology and Industrial Health 18, 289-296.[Abstract/Free Full Text]
• Ali-Osman, F., Akande, O. and Antoun, G.et al. 1997: Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pigene variants. Evidence for differential catalytic activity of the encoded proteins. Journal of Biological Chemistry 272, 10004-10012.[Abstract/Free Full Text]
• Arand, M., Mühlbauer, R. and Hengstler, J. 1996: A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Analytical Biochemistry 236, 184-186.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Benhamou, S., Reinikainen, M., Bouchardy, C.et al. 1998: Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Research 58, 5291-5293.[Abstract/Free Full Text]
• Bolt, H. M., Roos, P. H. and Their, R. 2003: The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. International Journal of Hygiene and Environmental Health 206, 149-171.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Carriere, V., Berthou, F. and Baird, S.et al. 1996: Human cytochrome P450-2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics 6, 203-211.[Web of Science][Medline] [Order article via Infotrieve]
• Crofts, F., Taioli, E. and Trachman, J.et al. 1994: Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15, 2961-2963.[Abstract/Free Full Text]
• Dick, F., Semple, S. and Osborne, A.et al. 2002: Organic solvent exposure, genes, and risk of neuropsychological impairment. QJM 95, 379-387.[Abstract/Free Full Text]
• Gonzalez, F. J. 2005: Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutation Research 569, 101-110.[Web of Science][Medline] [Order article via Infotrieve]
• Gsur, A., Zidek, T. and Schnattinger, K.et al. 2003: Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. British Journal of Cancer 89, 702-706.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Guengerich, F. P. and Turvy, C. G. 1991: Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. Journal of Pharmacology and Experimental Therapeutics 256, 1189-1194.[Abstract/Free Full Text]
• Hassett, C., Aicher, L. and Sidhu, J. S.et al. 1994: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Human Molecular Genetics 3, 421-428.[Abstract/Free Full Text]
• Haufroid, V., Buchet, J. P., Gardinal, S., et al. 2001: Importance of genetic polymorphisms of drug-metabolizing enzymes for the interpretation of biomarkers of exposure to styrene. Biomarkers 6, 236-249.[CrossRef]
• Hayashi, S., Watanabe, J. and Nakachi, K.et al. 1991: Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. Journal of Biochemistry (Tokyo) 110, 407-11.3.[Abstract/Free Full Text]
• Hirvonen, A. 2005: Gene environment interaction and biological monitoring of occupational exposures. Toxicology and Applied Pharmacology 207, 329-335.[CrossRef][Medline] [Order article via Infotrieve]
• Jaeschke, H., Gores, G. J. and Cederbaumm, A. I.et al. 2002: Mechanisms of hepatotoxicity. Toxicological Sciences 65, 166-176.[Abstract/Free Full Text]
• Korytina, G. F., Yanbaeva, D. G. and Babenkova, L. I.et al. 2005: Genetic polymorphisms in the cytochromes P-450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children. Journal of Molecular Medicine 83, 700-710.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kim, R. B., O’Shea, D. and Wilkinson, G. R. 1994: Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity. Pharmacogenetics 4, 162-165.[Web of Science][Medline] [Order article via Infotrieve]
• Laffon, B., Perez-Cadahia, B. and Pasaro, E.et al. 2003. Effect of epoxide hydrolase and glutathione S-transferase genotypes on the induction of micronuclei and DNA damage by styrene-7,8-oxide in vitro. Mutation Research 536, 49-59.[Web of Science][Medline] [Order article via Infotrieve]
• Mapp, C. E., Fryer, A. A. and De Marzo, N.et al. 2002: Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. Journal of Allergy and Clinical Immunology 109, 867-872.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mikkelsen, S. 1997: Epidemiological update on solvent neurotoxicity. Environmental Research 73, 101-112.[Medline] [Order article via Infotrieve]
• Miksys, S. and Tyndale, R. F. 2004: The unique regulation of brain cytochrome P450-2 (CYP2) family enzymes by drugs and genetics. Drug Metabolism Reviews 36, 313-333.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Oyama, T., Mitsudomi, T. and Kawamoto, T.et al. 1995: Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. International Archive of Occupational and Environ-ironmental Health 67, 253-256.
• Park, J. Y., Chen, L. and Wadhwa, N.et al. 2005: Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. International Journal of Molecular Medicine 15, 443-448.[Web of Science][Medline] [Order article via Infotrieve]
• Pirmohamed, M., Kitteringham, N. R. and Quest, L. J.et al. 1995: Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics 5, 351-357.[Web of Science][Medline] [Order article via Infotrieve]
• Ryberg, D., Skaug, V. and Hewer, A.et al. 1997: Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18, 1295-1299.
• Saarikoski, S. T., Voho, A. and Reinikainen, M.et al. 1998: Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. International Journal of Cancer 77, 516-521.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Savolainen, H. 1982: Toxicological mechanisms in acute and chronic nervous system degeneration. Acta Neurologica Scandinavica 66, 23-35.
• Schneider, J., Bernges, U. and Philipp, M.et al. 2004: GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Letters 208, 65-74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Smith, C. A. and Harrison, D. J. 1997: Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350, 630-633.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Söderkvist, P., Ahmadi, A. and Åkerbäck, A.et al. 1996: Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy. Scandinavian Journal of Work Environment and Health 22, 360-363.
• Sugimura, H., Hamada, G. S. and Suzuki, I.et al. 1995: CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil. Pharmacogenetics 5, S145-S148.[Medline] [Order article via Infotrieve]
• Thier, R., Bruning, T. and Roos, P. H.et al. 2003: Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. International Archive of Occupational and Environmental Health 76, 174-185.
• Uematsu, F., Kikuchi, H. and Motomiya, M.et al. 2002. Association between restriction fragment polymorphism of the human P450IIE1 gene and susceptibility to lung cancer. Environmental Health Perspectives 110, 1213-1218.[Web of Science][Medline] [Order article via Infotrieve]
• van der Hoek, J. A., Verberk, M. M. and van Hout, M. S. E.et al. 2002: From test to diagnosis; towards a coherent protocol for solvent-induced CTE. Congress on Neurobehavioral Methods and Effects in Occupational and Environmental Health, Brescia.
• Wan, J., Shi, J. and Hui, L.et al. 1991: Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Japanese Journal of Cancer Research 82, 254-256.[CrossRef][Web of Science]
• White, R. F. and Proctor, S. P. 1997: Solvents and neurotoxicity. Lancet 349, 1239-1243.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wong, R. H., Du, C. L. and Wang, J. D.et al. 2002: XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomer-exposed polyvinyl chloride workers. Cancer Epidemiology Biomarkers and Prevention 11, 475-482.[Abstract/Free Full Text]

Toxicology and Industrial Health, Vol. 22, No. 7, 281-289 (2006)
DOI: 10.1177/0748233706070287


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kezic, S. Articles by Verberk, M. M Search for Related Content PubMed PubMed Citation Articles by Kezic, S. Articles by Verberk, M. M Social Bookmarking                         What's this?